GCNT3 Antibodies

Santa Cruz Biotechnology delivers a wide array of GCNT3 monoclonal antibodies for advanced research in the field of glycosylation. GCNT3 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GCNT3, or Glucosaminyl (N-acetyl) transferase 3, plays a central role in the biosynthesis of complex N-glycans and is essential for the modulation of cell signaling and immune responses. GCNT3 activity significantly impacts cancer biology, as changes in glycosylation patterns can influence tumor progression and metastasis. Research has shown that GCNT3 expression levels vary across different tissue types and developmental stages. Understanding GCNT3 function and regulation provides valuable insights into disease mechanisms and potential therapeutic approaches. Studying GCNT3 helps reveal its role in normal cellular processes and various pathological conditions. Current research focuses on understanding how GCNT3 modifications affect cellular communication and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of GCNT3 and its impact on human health.